×
戻る Agenda
Closing
Speaker(s)
Closing Remarks
Sara Torgal, MPharm
DIA, Switzerland
Global Regulatory Policy Lead
Closing Remarks
Mats G. Hansson
Uppsala University, Sweden
IMI PREFER Coordinator & Senior Professor of Biomedical Ethics
Closing Remarks
Conny Berlin, MS
Novartis Pharma AG, Switzerland
IMI PREFER Project Leader & Global Head, Quantitative Safety and Epidemiology